(Q36432489)

14 August 2017

1 reference

title

Magnetic resonance imaging as a surrogate outcome measure of disability in multiple sclerosis: have we been overly harsh in our assessment? (English)

1 reference

14 August 2017

0 references

0 references

Douglas S Goodin

1

1 reference

14 August 2017

1 April 2006

1 reference

14 August 2017

1 reference

14 August 2017

59

1 reference

14 August 2017

4

1 reference

14 August 2017

597-605

1 reference

Clinicopathologic correlations of cranial magnetic resonance imaging of periventricular white matter.

14 August 2017

1 reference

A pathology-MRI study of the short-T2 component in formalin-fixed multiple sclerosis brain

21 January 2018

1 reference

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

21 January 2018

1 reference

Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis.

21 January 2018

1 reference

Clinical-MRI correlations in a European trial of interferon beta-1b in secondary progressive MS.

21 January 2018

1 reference

A questionnaire to assess neurological impairment in multiple sclerosis

21 January 2018

1 reference

Surrogate end points in clinical trials: are we being misled?

21 January 2018

1 reference

Subpial demyelination in the cerebral cortex of multiple sclerosis patients.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ANA.20832

1 reference

14 August 2017

1 reference

PubMed ID

16566022